MEA Dental Bone Graft Substitutes Market

MEA Dental Bone Graft Substitutes Market Size (2023 to 2028):

The size of the dental bone graft substitutes market is forecasted to be worth USD 57.28 million by 2028 from USD 36.18 million in 2023, registering a CAGR of 9.6% between 2023 and 2028.

The increase in bone and joint disorders is recognized as an important factor that can support the market's growth during the assessment period. The market expansion is expected to drive by the growing acceptance of dental bone grafts and the ongoing technological development. In addition, the increasing demand for high-quality musculoskeletal functions among the geriatric population is expected to drive the market significantly during the forecast period. Factors such as growing orthopedic issues, exponential geriatric population, and increasing demand for reconstructive orthopedic treatments drive the growth of the dental bone graft substitutes market.

The growing awareness of bone graft replacement technologies combined with increasing healthcare spending is expected to increase the size and revenue of the dental bone market in the coming years. In addition, the acceptance in the oral health sector of bone graft substitutes is another factor responsible for catalyzing the demand for bone graft substitutes during the evaluation period.

The costs associated with the surgery are likely to be an obstacle to the development of the market. Moreover, the risks and complications associated with bone grafting procedures are expected to present a significant challenge for the market in the coming period. However, the cost of installing and maintaining the equipment is a little high, which is slowing down the market demand.

Global demand for bone graft replacements has been affected due to the COVID-19, leading to a negative increase in the short term due to the temporary closure of clinics. Restricted access to clinics and blockages in different parts of the world has negatively affected the demand for bone substitutes. In addition, various state and national government agencies have established regulations that have helped delay elective surgeries and reallocate health services to deal with the pandemic. As supplies to manufacturing facilities have also declined, COVID-19 has affected the activities of many market players. In the context of the global COVID-19 pandemic, the demand for dental bone graft replacements by major end-users has declined significantly.

The key market participants are implementing several new strategies to develop their market, which is expected to intensify the market competition in the near future. In addition, the growing demand for high-quality health services should encourage companies to implement innovation in their products to improve competitiveness between products.

The increase in side effects due to the high dose of drugs remains a difficult factor for the MEA dental bone graft and substitutes market.

This research report on the MEA dental bone graft substitutes market has been segmented and sub-segmented into the following categories:

By Type:

• Synthetic Bone Graft
• Xenograft
• Allograft
• Demineralized Allograft

By Application: 

• Socket Preservation
• Ridge Augmentation
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Sinus Lift

By Product: 

• Bio OSS
• Osteograf
• Grafton

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the GCC countries are expected to account for the leading share in the MEA market during the forecast period due to the increasing initiatives taken by countries in the Middle East to develop their healthcare infrastructure, and the MEA is expected to grow significantly during the review period. Due to their economic stability, Middle Eastern countries such as UAE and Kuwait are expected to help strengthen the regional market.

Due to poor economic conditions, the African region is expected to hamper regional market expansion. However, the increased investment in hospitals by the government is taking advantage of market demand.

KEY MARKET PLAYERS:

A few of the leading companies operating in the MEA dental bone graft substitutes market profiled in the report are Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic, BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., LifeNet Health, and Dentium.